The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
Open accessAbstract
Three lines of evidence are presented that low density lipoproteins gently extracted from human and rabbit atherosclerotic lesions (lesion LDL) greatly resembles LDL that has been oxidatively modified in vitro. First, lesion LDL showed many of the physical and chemical properties of oxidized LDL, properties that differ from those of plasma LDL: higher electrophoretic mobility, a higher density, higher free cholesterol content, and a higher proportion of sphingomyelin and lysophosphatidylcholine in the phospholipid fraction. A number of lower molecular weight fragments of apo B were found in lesion LDL, similar to in vitro oxidized LDL. Second, both the intact apo B and some of the apo B fragments of lesion LDL reacted in Western blots with antisera that recognize malondialdehyde-conjugated lysine and 4-hydroxynonenal lysine adducts, both of which are found in oxidized LDL; plasma LDL and LDL from normal human intima showed no such reactivity. Third, lesion LDL shared biological properties with oxidized LDL: compared with plasma LDL, lesion LDL produced much greater stimulation of cholesterol esterification and was degraded more rapidly by macrophages. Degradation of radiolabeled lesion LDL was competitively inhibited by unlabeled lesion LDL, by LDL oxidized with copper, by polyinosinic acid and by malondialdehyde-LDL, but not by native LDL, indicating uptake by the scavenger receptor(s). Finally, lesion LDL (but not normal intimal LDL or plasma LDL) was chemotactic for monocytes, as is oxidized LDL. These studies provide strong evidence that atherosclerotic lesions, both in man and in rabbit, contain oxidatively modified LDL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.1.333 · Cited by 2,448
Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., & Steinberg, D. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3883 · Cited by 1,626
Self-citation[19] Receptor-mediated endocytosis of low-density lipoprotein in cultured cells
Goldstein, J. L., Basu, S. K., & Brown, M. S. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)98152-1 · Cited by 1,624
Low density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,519
Self-citationRg, G. (1981) · PubMed Central · Cited by 1,314
Quinn, M. T., Parthasarathy, S., Fong, L. G., & Steinberg, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2995 · Cited by 1,137
Self-citationSalacinski, P. R. P., McLean, C., Sykes, J. E. C., Clement-Jones, V. V., & Lowry, P. J. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90703-x · Cited by 1,129
Carew, T. E., Schwenke, D. C., & Steinberg, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7725 · Cited by 1,035
Self-citation
Cited by
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Antioxidants in health and disease
Young, I. S., & Woodside, J. V. (2001) · Journal of Clinical Pathology · doi:10.1136/jcp.54.3.176 · Cited by 1,949
“106 In young survivors of myocardial infarction (MI), an association has been demonstrated between increased susceptibility of LDL to oxidation and the degree of coronary atherosclerosis, 107 whereas the presence of ceroid, a product of lipid peroxidation, has been shown in advanced atherosclerotic…”
BackgroundOxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,701
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
The role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,366
Antioxidants and Atherosclerotic Heart Disease
Diaz, M. N., Frei, B., Vita, J. A., & Keaney, J. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370607 · Cited by 1,353
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
Salonen, J. T., Korpela, H., Salonen, R., Nyyssonen, K., Yla-Herttuala, S., Yamamoto, R., Butler, S., Palinski, W., & Witztum, J. L. (1992) · The Lancet · doi:10.1016/0140-6736(92)90926-t · Cited by 1,316
Self-citationDaugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Antioxidants and Prevention of Chronic Disease
WILLCOX, J. K., ASH, S. L., & CATIGNANI, G. L. (2004) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690490468489 · Cited by 1,188
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Napoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014
“Previous studies combining immunocytochemistry and Western blot analysis of LDL extracted from lesions also support this conclusion (57).”
ResultSelf-citationFrostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Dietary Antioxidant Vitamins and Death from Coronary Heart Disease in Postmenopausal Women
Kushi, L. H., Folsom, A. R., Prineas, R. J., Mink, P. J., Wu, Y., & Bostick, R. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341803 · Cited by 960
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.
Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., & Hansson, G. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3893 · Cited by 943
Self-citationCarr, A. C., & Frei, B. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1086 · Cited by 940
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Self-citationKugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., & Henry, P. D. (1990) · Nature · doi:10.1038/344160a0 · Cited by 858
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
Self-citationBrown, B. G., Zhao, X. Q., Sacco, D. E., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.87.6.1781 · Cited by 821
A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism
Febbraio, M., Abumrad, N. A., Hajjar, D. P., Sharma, K., Cheng, W., Pearce, S. F. A., & Silverstein, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19055 · Cited by 769
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769
Ip, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B., & Chesebro, J. H. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92845-s · Cited by 765
Lewis A. Conner Memorial Lecture: Oxidative Modification of LDL and Atherogenesis
Steinberg, D. (1997) · Circulation · doi:10.1161/01.cir.95.4.1062 · Cited by 748
Self-citationThe oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Self-citationRicote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., & Glass, C. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7614 · Cited by 721
Self-citationde Graaf, J., Hak-Lemmers, H. L., Hectors, M. P., Demacker, P. N., Hendriks, J. C., & Stalenhoef, A. F. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., Van Lenten, B. J., Frank, J. S., Demer, L. L., et al. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.7.831 · Cited by 692
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Fuhrman, B., Lavy, A., & Aviram, M. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.3.549 · Cited by 675
Prospects for the Use of Antioxidant Therapies
Maxwell, S. R. J. (1995) · Drugs · doi:10.2165/00003495-199549030-00003 · Cited by 664
Protein-bound acrolein: Potential markers for oxidative stress
Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y., Suzuki, D., Miyata, T., Noguchi, N., Niki, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4882 · Cited by 632
Palinski, W., Ylä-Herttuala, S., Rosenfeld, M. E., Butler, S. W., Socher, S. A., Parthasarathy, S., Curtiss, L. K., & Witztum, J. L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.3.325 · Cited by 616
Self-citationRole of oxidatively modified LDL in atherosclerosis
Steinbrecher, U. P., Zhang, H., & Lougheed, M. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90119-4 · Cited by 603
Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell, L. J., Arnold, L., Flowers, D., Waeg, G., Malle, E., & Stocker, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118576 · Cited by 592
O’Brien, K. D., McDonald, T. O., Chait, A., Allen, M. D., & Alpers, C. E. (1996) · Circulation · doi:10.1161/01.cir.93.4.672 · Cited by 573
Hörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Self-citationPalinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Self-citationGalis, Z. S., Sukhova, G. K., Kranzhöfer, R., Clark, S., & Libby, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.402 · Cited by 556
Chait, A., Brazg, R. L., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554
Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
Ylä-Herttuala, S., Palinski, W., Butler, S. W., Picard, S., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.32 · Cited by 548
Self-citationAcrolein Is a Product of Lipid Peroxidation Reaction
Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N., & Niki, E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16058 · Cited by 546
Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase
Liao, J. K., Shin, W. S., Lee, W. Y., & Clark, S. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.319 · Cited by 541
The Role of Oxidative Stress in Diabetic Complications
Niedowicz, D. M., & Daleke, D. L. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:2:289 · Cited by 524
Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E–deficient mice
Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F., & Funk, C. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5897 · Cited by 523
Self-citationInflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. J. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
A CD36-dependent signaling cascade is necessary for macrophage foam cell formation
Rahaman, S. O., Lennon, D. J., Febbraio, M., Podrez, E. A., Hazen, S. L., & Silverstein, R. L. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.06.007 · Cited by 506
Atherogenic Lipoprotein Particles in Atherosclerosis
Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation · doi:10.1161/01.cir.0000131511.50734.44 · Cited by 494
Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
Self-citationCan antioxidant vitamins materially reduce oxidative damage in humans?
McCall, M. R., & Frei, B. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00302-5 · Cited by 485
Association of low serum concentration of bilirubin with increased risk of coronary artery disease
Schwertner, H. A., Jackson, W. G., & Tolan, G. (1994) · Clinical Chemistry · doi:10.1093/clinchem/40.1.18 · Cited by 474
Rosenfeld, M. E., Palinski, W., Ylä-Herttuala, S., Butler, S., & Witztum, J. L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.3.336 · Cited by 474
Self-citationOxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans
Chou, M.-Y., Fogelstrand, L., Hartvigsen, K., Hansen, L. F., Woelkers, D., Shaw, P. X., Choi, J., Perkmann, T., Bäckhed, F., Miller, Y. I., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36800 · Cited by 468
Self-citationTribble, D. L., Holl, L. G., Wood, P. D., & Krauss, R. M. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90255-f · Cited by 467
Nagao, T., Komine, Y., Soga, S., Meguro, S., Hase, T., Tanaka, Y., & Tokimitsu, I. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.122 · Cited by 467
Heinecke, J. W. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00173-7 · Cited by 466
Khan, B. V., Parthasarathy, S. S., Alexander, R. W., & Medford, R. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117776 · Cited by 463
Self-citationZeiher, A. M., Fisslthaler, B., Schray-Utz, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.6.980 · Cited by 462
Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D., & Rosenblat, M. (2000) · Circulation · doi:10.1161/01.cir.101.21.2510 · Cited by 460
Oxidized Low-Density Lipoprotein and Atherosclerosis
Steinberg, D., & Witztum, J. L. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179697 · Cited by 460
Self-citationParthasarathy, S., Khoo, J. C., Miller, E., Barnett, J., Witztum, J. L., & Steinberg, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3894 · Cited by 459
Self-citationNardini, M., D'Aquino, M., Tomassi, G., Gentili, V., Di Felice, M., & Scaccini, C. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00052-y · Cited by 458
Darley-usmar, V. M., Hogg, N., O'leary, V. J., Wilson, M. T., & Moncada, S. (1992) · Free Radical Research Communications · doi:10.3109/10715769209061085 · Cited by 456
Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
Chin, J. H., Azhar, S., & Hoffman, B. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115549 · Cited by 450
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
Witztum, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00111-6 · Cited by 440
Self-citation4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interest
Poli, G., Schaur, R. J., Siems, W. G., & Leonarduzzi, G. (2008) · Medicinal Research Reviews · doi:10.1002/med.20117 · Cited by 433
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Glass, C. K., Sigal, E., Witztum, J. L., & Steinberg, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6959 · Cited by 426
Self-citationBalla, G., Jacob, H. S., Eaton, J. W., Belcher, J. D., & Vercellotti, G. M. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.6.1700 · Cited by 420
Inflammation during the life cycle of the atherosclerotic plaque
Libby, P. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab303 · Cited by 414
Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability
Nishi, K., Itabe, H., Uno, M., Kitazato, K. T., Horiguchi, H., Shinno, K., & Nagahiro, S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033829.14012.18 · Cited by 409
Innate sensing of oxidation-specific epitopes in health and disease
Binder, C. J., Papac-Milicevic, N., & Witztum, J. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.63 · Cited by 403
“PCOxPL, MDA, 4HNE, OxCE and CEP have all been documented in atherosclerotic lesions in humans and in animal models of disease 46, 76, [113] [114] [115] .”
BackgroundSelf-citationToshima, S.-I., Hasegawa, A., Kurabayashi, M., Itabe, H., Takano, T., Sugano, J., Shimamura, K., Kimura, J., Michishita, I., Suzuki, T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2243 · Cited by 407
Reaven, P. D., Khouw, A., Beltz, W. F., Parthasarathy, S., & Witztum, J. L. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.590 · Cited by 405
Self-citationEndothelium-derived contracting factors.
Lüscher, T. F., Boulanger, C. M., Dohi, Y., & Yang, Z. H. (1992) · Hypertension · doi:10.1161/01.hyp.19.2.117 · Cited by 401
Gas chromatographic analysis of fatty acid methyl esters
Eder, K. (1995) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00142-6 · Cited by 389
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease
Jiang, X.-C., Paultre, F., Pearson, T. A., Reed, R. G., Francis, C. K., Lin, M., Berglund, L., & Tall, A. R. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2614 · Cited by 386
Carr, A. C., McCall, M. R., & Frei, B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1716 · Cited by 386
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
Ishii, S., & Shimizu, T. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(99)00016-8 · Cited by 384
Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Sigal, E., Särkioja, T., Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115111 · Cited by 379
Self-citationOn the antioxidant effects of ascorbic acid and glutathione
Meister, A. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90091-v · Cited by 378
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
Self-citationReaven, P., Parthasarathy, S., Grasse, B. J., Miller, E., Steinberg, D., & Witztum, J. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116247 · Cited by 374
Self-citationThe Effect of α-Tocopherol Supplementation on LDL Oxidation: A Dose-Response Study
Jialal, I., Fuller, C. J., & Huet, B. A. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.2.190 · Cited by 368
Inflammatory biomarkers in coronary artery disease
Zakynthinos, E., & Pappa, N. (2009) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.12.007 · Cited by 359
Suarna, C., Dean, R. T., May, J., & Stocker, R. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1616 · Cited by 355
Rapp, J. H., Lespine, A., Hamilton, R. L., Colyvas, N., Chaumeton, A. H., Tweedie-Hardman, J., Kotite, L., Kunitake, S. T., Havel, R. J., & Kane, J. P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1767 · Cited by 340
Dansky, H. M., Charlton, S. A., Harper, M. M., & Smith, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4642 · Cited by 346
Hulthe, J., & Fagerberg, B. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021150.63480.cd · Cited by 345
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344
Schissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., & Tabas, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118934 · Cited by 341
Savenkova, M. L., Mueller, D. M., & Heinecke, J. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32005-7 · Cited by 335
Metadata
- Authors
- Ylä-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., & Steinberg, D.
- Venue
- Journal of Clinical Investigation
- Published
- 1989-10-01
- Volume
- 84
- Issue
- 4
- Pages
- 1086-1095
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2104573407
- Cited by
- 1,880
- References
- 50
- FWCI
- 24.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.